Skip to main content
Article thumbnail
Location of Repository

Rapid Detection of Carbapenem Resistance in Acinetobacter baumannii Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

By Marie Kempf, Sofiane Bakour, Christophe Flaudrops, Meryem Berrazeg, Jean-Michel Brunel, Mourad Drissi, Esma Mesli, Abdelaziz Touati and Jean-Marc Rolain

Abstract

Rapid detection of carbapenem-resistant Acinetobacter baumannii strains is critical and will benefit patient care by optimizing antibiotic therapies and preventing outbreaks. Herein we describe the development and successful application of a mass spectrometry profile generated by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) that utilized the imipenem antibiotic for the detection of carbapenem resistance in a large series of A. baumannii clinical isolates from France and Algeria. A total of 106 A. baumannii strains including 63 well-characterized carbapenemase-producing and 43 non-carbapenemase-producing strains, as well as 43 control strains (7 carbapenem-resistant and 36 carbapenem-sensitive strains) were studied. After an incubation of bacteria with imipenem for up to 4 h, the mixture was centrifuged and the supernatant analyzed by MALDI-TOF MS. The presence and absence of peaks representing imipenem and its natural metabolite was analyzed. The result was interpreted as positive for carbapenemase production if the specific peak for imipenem at 300.0 m/z disappeared during the incubation time and if the peak of the natural metabolite at 254.0 m/z increased as measured by the area under the curves leading to a ratio between the peak for imipenem and its metabolite being <0.5. This assay, which was applied to the large series of A. baumannii clinical isolates, showed a sensitivity of 100.0% and a specificity of 100.0%. Our study is the first to demonstrate that this quick and simple assay can be used as a routine tool as a point-of-care method for the identification of A. baumannii carbapenemase-producers in an effort to prevent outbreaks and the spread of uncontrollable superbugs

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3280980
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2011). A Diversity of OXACarbapenemases and Class 1 Integrons Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Sweden Belonging to Different International Clonal Lineages. Microb Drug Resist. doi: 10.1089/ mdr.2011.0089.
    2. (2011). Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France.
    3. (2005). C o l i s t i nt r e a t m e n ti np a t i e n t sw i t hI C U - a c q u i r e di n f e c t i o n sc a u s e db y multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
    4. (2006). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    5. (2011). Carbapenem Susceptibility Testing Errors Using Three Automated Systems,
    6. (2011). Carbapenemase activity detection by matrix-assisted laser desorption ionizationtime of flight mass spectrometry.
    7. (2011). Comparative activity of carbapenem testing: the COMPACT study.
    8. (2006). Comparative genomics of multidrug resistance
    9. (1986). Degradation kinetics of imipenem in normal saline and in human serum.
    10. (2010). Diversity, epidemiology, and genetics of class D beta-lactamases.
    11. (2011). Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    12. (2002). Emerging carbapenemases in Gram-negative aerobes.
    13. (2011). Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect.
    14. (2003). Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallobeta-lactamase-producing isolates of Pseudomonas spp.a n dAcinetobacter spp.
    15. (2011). Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000–09).
    16. (2011). Genetic diversity of carbapenem-hydrolysing beta-lactamases in Acinetobacter baumannii from Romanian hospitals.
    17. (2010). High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories.
    18. (2010). Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: usefulness for taxonomy and epidemiology.
    19. (2011). Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia.
    20. (2006). Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.
    21. (2009). Ongoing revolution in bacteriology: routine identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    22. (2011). Protein Identification Using Nano-HPLC-MS:
    23. (2011). Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China.
    24. (2009). Tsakris A
    25. (2011). Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry To Detect Carbapenem Resistance within 1 to 2.5 Hours.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.